Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms (2016)
- Authors:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1186/s13000-016-0476-4
- Subjects: LEUCEMIA MIELOIDE AGUDA; BIOMARCADORES; PROTEÍNAS PROTO-ONCOGÊNICAS
- Keywords: Ten-eleven-translocation 2; TET2; Mutation; Myelodysplastic syndromes; Acute myeloid leukemia
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Diagnostic Pathology
- ISSN: 1746-1596
- Volume/Número/Paginação/Ano: v. 11, n.1, art. 28, 2016
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SCOPIM-RIBEIRO, Renata et al. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms. Diagnostic Pathology, v. 11, n. 1, 2016Tradução . . Disponível em: https://doi.org/10.1186/s13000-016-0476-4. Acesso em: 24 abr. 2024. -
APA
Scopim-Ribeiro, R., Machado Neto, J. A., Campos, P. de M., Niemann, F. S., Lorand-Metze, I., Costa, F. F., et al. (2016). Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms. Diagnostic Pathology, 11( 1). doi:10.1186/s13000-016-0476-4 -
NLM
Scopim-Ribeiro R, Machado Neto JA, Campos P de M, Niemann FS, Lorand-Metze I, Costa FF, Saad STO, Traina F. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms [Internet]. Diagnostic Pathology. 2016 ; 11( 1):[citado 2024 abr. 24 ] Available from: https://doi.org/10.1186/s13000-016-0476-4 -
Vancouver
Scopim-Ribeiro R, Machado Neto JA, Campos P de M, Niemann FS, Lorand-Metze I, Costa FF, Saad STO, Traina F. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms [Internet]. Diagnostic Pathology. 2016 ; 11( 1):[citado 2024 abr. 24 ] Available from: https://doi.org/10.1186/s13000-016-0476-4 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- MDR-1 and GST polymorphisms are involved in myelodysplasia progression
Informações sobre o DOI: 10.1186/s13000-016-0476-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
